CEACAM1 and breast carcinoma: Since loss of CEACAM1 represents a clear adverse prognosis parameter in WAP-T mouse mammary carcinomas, we took advantage of a publicly available database, www.klplot.com, to assess the impact of CEACAM1 expression levels on breast cancer patient survival [55, 56].